Literature DB >> 18184286

Screening and behavioral management: obesity and weight management.

Robert Nicholson1, Marcelo Bigal.   

Abstract

Individuals with migraine headaches who are obese or overweight may be at elevated risk for experiencing more frequent migraines and for developing chronic migraine. This makes it imperative that clinicians consider including weight management as part of a migraine treatment plan in situations where the patient is overweight or obese. Weight loss and weight maintenance therapy should employ a combination of behavioral strategies, in particular nutritional education, dietary intervention, and exercise counseling, as a first line intervention. Weight loss medications are considered a secondary treatment; however, when weight loss medications are used, it is vital to monitor the influence of the medication on headache. Similarly, a clinician considering migraine prophylaxis needs to consider whether the pharmacologic agent being considered influences weight gain or loss.

Entities:  

Mesh:

Year:  2008        PMID: 18184286      PMCID: PMC2408879          DOI: 10.1111/j.1526-4610.2007.00975.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  38 in total

Review 1.  Preventive treatment of migraine: effect on weight.

Authors:  W B Young; T D Rozen
Journal:  Cephalalgia       Date:  2005-01       Impact factor: 6.292

2.  Moderators and mediators of behavioral treatment for headache.

Authors:  Robert A Nicholson; Karl G Hursey; Justin M Nash
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

3.  Randomized trial of lifestyle modification and pharmacotherapy for obesity.

Authors:  Thomas A Wadden; Robert I Berkowitz; Leslie G Womble; David B Sarwer; Suzanne Phelan; Robert K Cato; Louise A Hesson; Suzette Y Osei; Rosalind Kaplan; Albert J Stunkard
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Impairment of health and quality of life using new US federal guidelines for the identification of obesity.

Authors:  M E Lean; T S Han; J C Seidell
Journal:  Arch Intern Med       Date:  1999-04-26

Review 5.  Topiramate in migraine prevention.

Authors:  Stephen D Silberstein
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

6.  Prospective study of body mass index and risk of stroke in apparently healthy women.

Authors:  Tobias Kurth; J Michael Gaziano; Kathryn M Rexrode; Carlos S Kase; Nancy R Cook; Joann E Manson; Julie E Buring
Journal:  Circulation       Date:  2005-04-19       Impact factor: 29.690

7.  Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians.

Authors:  Vincenza Snow; Patricia Barry; Nick Fitterman; Amir Qaseem; Kevin Weiss
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

8.  Pain in the obese: impact on health-related quality-of-life.

Authors:  I Barofsky; K R Fontaine; L J Cheskin
Journal:  Ann Behav Med       Date:  1997

9.  Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.

Authors:  M L Stefanick; S Mackey; M Sheehan; N Ellsworth; W L Haskell; P D Wood
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

10.  Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.

Authors:  Ferdinando Maggioni; Silvia Ruffatti; Filippo Dainese; Federico Mainardi; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2005-09       Impact factor: 7.277

View more
  9 in total

Review 1.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

2.  Improvement of migraine headaches in severely obese patients after bariatric surgery.

Authors:  D S Bond; S Vithiananthan; J M Nash; J G Thomas; R R Wing
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

Review 3.  Behavioral Weight Loss Treatments for Individuals with Migraine and Obesity.

Authors:  Cynthia Cervoni; Dale S Bond; Elizabeth K Seng
Journal:  Curr Pain Headache Rep       Date:  2016-02

4.  Bariatric Surgery in Migraine patients: CGRP Level and Weight Loss.

Authors:  Helia Hemasian Etefagh; Shahab Shahabi Shahmiri; Hamid Melali; Masoud Sayadi; Hossein Ansari; Arvin Shahzamani; Mitra Sadat Deyhimi
Journal:  Obes Surg       Date:  2022-08-03       Impact factor: 3.479

5.  Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial.

Authors:  Dale S Bond; Kevin C O'Leary; J Graham Thomas; Richard B Lipton; George D Papandonatos; Julie Roth; Lucille Rathier; Richard Daniello; Rena R Wing
Journal:  Contemp Clin Trials       Date:  2013-03-22       Impact factor: 2.226

6.  Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations.

Authors:  Randall E Weeks
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

7.  Behavioral Weight Loss Intervention for Migraine: A Randomized Controlled Trial.

Authors:  Dale S Bond; J Graham Thomas; Richard B Lipton; Julie Roth; Jelena M Pavlovic; Lucille Rathier; Kevin C O'Leary; E Whitney Evans; Rena R Wing
Journal:  Obesity (Silver Spring)       Date:  2017-11-27       Impact factor: 5.002

8.  Factors Predictive of Quality of Life among Breast Cancer Patients

Authors:  Amira Daldoul; Wieme Khechine; Hanene Bhiri; Nouha Ammar; Rym Bouriga; Mohamed Wassim Krir; Said Soltani; Olfa Zoukar; Mohamed Salah Rhim; Sarra Bouslah; Sabrine Dimassi; Ibtissem Abbess; Zahra Saidani; Sonia Zaied
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

9.  Integrative East-West Medicine Intervention for Chronic Daily Headache: A Case Report and Care Perspective.

Authors:  Justin G Laube; Thais Salles Araujo; Lawrence B Taw
Journal:  Glob Adv Health Med       Date:  2020-02-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.